iShares Core S&P 500 ETF vs 10X Genomics Inc — how do they compare? iShares Core S&P 500 ETF trades at $776.01, while 10X Genomics Inc trades at $59.24 (market cap $7.61B). Which is the better fit depends on your goals.
| IVV | TXG | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $776.81 | $58.57 |
52-Week Low | $634.93 | $11.34 |
Market Cap | — | $7.61B |
Enterprise Value | — | $7.14B |
Signals from Pluang's Aura AI — not financial advice
IVV, tracking the S&P 500, trades at $776.81, up 0.6% with a bullish technical signal from moving averages. The ETF approaches resistance near $779-$784 amid strong institutional interest, including a 24.8% position increase by First Bank & Trust. Recent news highlights record highs and JPMorgan's raised 2026 target to 8,000, driven by AI-fueled earnings growth.
Outlook remains positive with S&P 500 earnings growth up 51.1% year-over-year, but risks include overbought conditions (RSI_6 at 94.32) and potential consolidation. Investor sentiment is greedy, yet weak market breadth and high valuations warrant caution for near-term volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →